This company is ready to flood the US with cheap HIV drugs

US patents on key components for some important HIV therapies are poised to expire starting in December and Laurus Labs -- the Hyderabad, India-based company which owns the facility -- is gearing up to cash in.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news